The article highlights Anavex Life Sciences as a short-squeeze candidate due to its rising share prices and high short interest, which is over 23%. This suggests potential upward pressure on the stock as short-sellers may be forced to cover their positions. Additionally, growing institutional and analyst support further strengthens the bullish sentiment.